MS News & Perspectives

MS News & Perspectives

Multiple Sclerosis News Today seeks to fill an unmet need in healthcare news journalism by providing patients and their families with a reliable news journal on MS that they can engage with on a daily basis for the latest news and MS resources.

Den här podcasten är hämtad från ett öppet RSS-flöde och publiceras inte av Podme. Den kan innehålla reklam.

Avsnitt(500)

Study Aims for Better Way of Marking Myelination & Coping With Loss and MS

Study Aims for Better Way of Marking Myelination & Coping With Loss and MS

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on a study aimed at developing precise markers of myelination in people with MS. He also reads “To Everyth...

29 Juli 202210min

Jenn Talks to Kathy Young, Patient Advocate

Jenn Talks to Kathy Young, Patient Advocate

Kathy Reagan Young is the founder of website and podcast FUMS. She is also the founder of Patients Getting Paid, a membership community that helps people with chronic illnesses find employment that ac...

28 Juli 202241min

Intermittent Fasting Leads to Metabolic Changes & Business Decisions After PPMS Diagnosis

Intermittent Fasting Leads to Metabolic Changes & Business Decisions After PPMS Diagnosis

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news article on how data from a small clinical trial showed how an intermittent fasting diet plan led to immune cell a...

27 Juli 202212min

Long-term Zeposia May Help Cognitive Function & No Relapse Doesn’t Mean Symptom-free

Long-term Zeposia May Help Cognitive Function & No Relapse Doesn’t Mean Symptom-free

In this audio news episode, Price Wooldridge reads an article on how long-term treatment with Zeposia seems to stabilize or improve cognitive function in most adults with relapsing forms of MS. He als...

25 Juli 202210min

Tolebrutinib Trials Paused Over Safety Concerns & Setback for MS Spasticity Treatment

Tolebrutinib Trials Paused Over Safety Concerns & Setback for MS Spasticity Treatment

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how new U.S. enrollments in Phase 3 trials of tolebrutinib for MS have been paused due to some reports of liver injury...

22 Juli 20229min

Higher Covid-19 Risk Tied to 2 MS Therapies & With MS Good Planning Is Key

Higher Covid-19 Risk Tied to 2 MS Therapies & With MS Good Planning Is Key

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge reads an article about how fully vaccinated MS patients who are taking Ocrevus or Gilenya have a higher risk of COVID-19 infectio...

20 Juli 202211min

Mavenclad Efficacy, Safety Similar to Trials & Staying Cool in the Summer Heat

Mavenclad Efficacy, Safety Similar to Trials & Staying Cool in the Summer Heat

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge explains how the safety and efficacy of Mavenclad in a real-world group of RRMS patients, were similar to what was observed in it...

18 Juli 20229min

Remyelinated Brain Lesions Visible Via MRI & Managing Conflicting Feelings

Remyelinated Brain Lesions Visible Via MRI & Managing Conflicting Feelings

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how researchers found that an MRI technique can be used to accurately identify remyelinated brain les...

15 Juli 202210min

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
kapitalet-en-podd-om-ekonomi
svd-nyhetsartiklar
rss-ufobortom-rimligt-tvivel
bildningspodden
rss-vetenskapsradion
medicinvetarna
halsorevolutionen
dumforklarat
det-morka-psyket
rss-vetenskapsradion-2
rss-arkeologi-historia-podden-som-graver-i-vart-kulturlandskap
vetenskapsradion
paranormalt-med-caroline-giertz
rss-spraket
sexet
rss-ronden
4health-med-anna-sparre